Elevated plasma concentrations of lipoprotein (a)[Lp (a)] have been determined to be a
causal risk factor for coronary heart disease, and may similarly play a role in other …

Over the past four decades, no class of drugs has had more impact on cardiovascular health
than the 3-hydroxy-methylglutaryl coenzyme A reductase inhibitors or statins. Developed as …

Platelets and coagulation factors are involved in the process of haemostasis, which ensures
undisturbed blood flow upon vessel wall damage. However, excessive platelet aggregation …

Background: The relationship between cholesterol levels and risk of venous
thromboembolism (VTE) is uncertain. We set out to determine the effect of PCSK9 …

Thrombosis is the defining feature of the most prevalent causes of cardiovascular mortality,
such as myocardial infarction, stroke, and pulmonary artery embolism. Although platelet …

Background: Previous studies have shown that idiopathic pulmonary embolism is positively
associated with other cardiovascular events, such as myocardial infarction and stroke …

Central obesity is a key feature of the metabolic syndrome (metS), a multiplex risk factor for
subsequent development of type 2 diabetes and cardiovascular disease. Many metabolic …

Objects To investigate the potential clinical significance between blood lipid levels and
lower extremity deep venous thrombosis (LEDVT). Methods: This cohort study included 500 …

There is still some controversy about the relationship between lipids and venous thrombosis
(VTE). A bidirectional Mendelian randomization (MR) study was conducted to clarify the …

Background Asparaginase and steroids can cause hypertriglyceridaemia in children with
acute lymphoblastic leukaemia (ALL). There are no guidelines for screening or management …